Merck all news related to

Medical department receives 2 million capsules of drug that can fight Covid

March 18, 2022

The Medical Services Department on Friday received 2 million capsules of Molnupiravir drug from a subsidiary of pharmaceutical company Merck.

Thailand to go ahead with Molnupiravir order despite a marked drop in pill’s efficacy

December 28, 2021

Thailand will go ahead with its order of 2 million tablets of the Covid-19 magic pill Molnupiravir despite news that France has cancelled its order due to disappointing test results, Dr Somsak Akksilp, Department of Medical Services director-general, said on Monday.

Japanese panel approves Merck’s COVID-19 pill

SATURDAY, DECEMBER 25, 2021

TOKYO (Jiji Press) — Health minister Shigeyuki Goto on Friday approved Merck & Co.’s COVID-19 pill molnupiravir for use in the country, making it the first oral treatment for coronavirus patients with mild symptoms in Japan.

FDA authorizes Mercks anti-coronavirus pill, a second treatment option

THURSDAY, DECEMBER 23, 2021

Federal regulators authorized a second pill to treat covid-19 Thursday, adding another at-home treatment option to help keep high-risk people out of the hospital.

Expert explains differences between two Covid-19 magic pills

TUESDAY, NOVEMBER 09, 2021

The Public Health Ministry on Monday explained the differences between Merck’s Molnupiravir and Pfizer’s Paxilovid pills, both of which help reduce severe symptoms and death from Covid-19. The aim is to make these drugs widely available in Thailand by early next year.

PM satisfied country ranks 18th in vaccination rate

MONDAY, NOVEMBER 08, 2021

Prime Minister Prayut Chan-o-cha is satisfied Thailands Covid vaccination rate has surpassed 80 million doses, ranking 18th out of 184 countries, government spokesman Thanakorn Wangboonkonghchana said on Monday.

Britain authorizes Mercks covid-19 treatment pill molnupiravir, in the worlds first approval of drug

FRIDAY, NOVEMBER 05, 2021

LONDON - Regulators in Britain granted approval to the experimental drug molnupiravir from U.S. pharmaceutical giant Merck on Thursday, marking the first authorization from a public health body for an oral antiviral treatment for covid-19 in adults.

Merck projects billions in sales of covid antiviral Molnupiravir

FRIDAY, OCTOBER 29, 2021

Merck & Co.s closely watched covid-19 antiviral molnupiravir could bring in as much as $7 billion in global sales through 2022, according to the drugmaker.

U.S. drug company Merck to share license for experimental covid-19 treatment with non-profit

THURSDAY, OCTOBER 28, 2021

U.S. pharmaceutical giant Merck has agreed to share its license for its experimental covid-19 drug, molnupiravir, with a nonprofit organization so that it can be manufactured widely around the world in a deal that would expand access to the treatment in more than 100 countries.

Gates aims to accelerate global access to Mercks covid pill

THURSDAY, OCTOBER 21, 2021

The Bill & Melinda Gates Foundation said millions of courses of Merck & Co.s promising pill for Covid-19 could begin to reach lower-income nations early next year as the charity kicks in as much as $120 million to widen global access to the therapy.

S. Korea’s hope for normalization boosted with positive trial results from Merck

SUNDAY, OCTOBER 03, 2021

South Korea’s plan to step into a phased recovery back to normal life in November is gaining support with positive clinical test results of an experimental COVID-19 oral medication overseas.

Merck will help make Johnson & Johnson coronavirus vaccine as rivals team up to help Biden accelerate shots

WEDNESDAY, MARCH 03, 2021

WASHINGTON - President Joe Biden announced Tuesday that pharmaceutical giant Merck will help make Johnson & Johnson's single-shot coronavirus vaccine - an unusual pact between fierce rivals that is among several steps intended to boost supply as Biden pushes toward having enough shots for every adult by the end of May.

All News Merck In Focus Merck BreakingNews of Merck Your Interested Follow Story Merck